Old drugs, new ideas. That’s one of the core drivers of using artificial intelligence (AI) for drug development. Researchers using complex AI-fueled methods are now taking aim at what has become a ...

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, today announced that it has been named a leading innovator in AI drug ...

Amadeus Capital Partners and Abcam founder Jonathan Milner have teamed up to invest in Healx, a British startup working with patient advocacy groups to repurpose drugs for rare diseases. Healx will ...

In a systematic review published in Quantitative Biology, researchers from West Virginia University (WVU) and their collaborators critically examined the transformative impact of ChatGPT in the fields ...

Algorithms used for consumer predictions are being retooled to help identify which medicines are optimal and may carry hidden risks for patients. Researchers from Monash University used a different ...

Baritinib is a drug to treat rheumatoid arthritis. After outbreak of COVID-19, Benevolent AI Company discovered that AAK1 is a regulatory factor in the process of SARS-CoC-2 infection by generating a ...

Experimental means have advanced significantly since the early years of paper, wire, stick, and ball modeling techniques and now include mathematical approaches that use advanced computer systems and ...

Researchers are studying whether existing, safe medicines could be adapted to treat dementia. This is known as drug repurposing, and it offers fresh hope for finding effective dementia treatments ...

Scientists have identified a potential new treatment strategy for Alzheimer’s disease using a combination of two existing ...